Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IB Study of Hydroxychloroquine Prior to Nephrectomy in Patients With Primary Renal Cell Carcinoma

NCT01144169 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT01144169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01144169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IB Study of Hydroxychloroquine Prior to Nephrectomy in Patients With Primary Renal Cell Carcinoma
Lead sponsor
University of Pittsburgh
Phase
Phase 1
Overall status
Terminated
Start date
October 31, 2010
Completion date
September 30, 2016
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma